The IBN SINA Pharmaceutical Industry PLC reported earnings results for the third quarter and nine months ended March 31, 2023. For the third quarter, the company reported sales was BDT 2,022.84 million compared to BDT 1,879.43 million a year ago. Net income was BDT 93.25 million compared to BDT 86.62 million a year ago.
For the nine months, sales was BDT 6,638.95 million compared to BDT 6,407.26 million a year ago. Net income was BDT 422.29 million compared to BDT 414.5 million a year ago. Basic earnings per share from continuing operations was BDT 13.52.